layout: strict-home-rr title: “NCN: Neutralizing Botulinum Toxin Type A Antibodies:Clinical Observations in Patients with Cervical Dystonia - Rollnik”

Logo: NCN Neurology and Clinical Neurophysiology
About
Articles Approved
Articles Received
Editorial Board
Submission Guidelines
Subscribe
Subscriber Rights
AACN Homepage
Contact
<- Back to Articles Approved

Characterizing Neuropathies Associated With Monoclonal Gammopathy of Undetermined Significance (MGUS): A Framework Consistent With Classifying Injuries According to Fiber Size

Morris A. Fisher, MD
John R. Wilson, MD

READ FULL ARTICLE PDF

Published: May 2002

Neuropathies associated with monoclonal gammopathy of undetermined significance (MGUS) occur frequently in the elderly. Data from 42 consecutive elderly patients with a MGUS-associated neuropathy—12 patients with IgM MGUS,25 patients with IgG MGUS,5 patients with IgA MGUS — were evaluated prospectively using quantifiable clinical criteria and quantitative sensory testing. Results consistent with preferential injury to large fibers were found in patients with IgM isotypes ( P < .005) but not in patients with IgG isotypes ( P < .0005 to .0004). These findings support an immunologic origin for at least some MGUS-associated neuropathies and provide information important for the clinical evaluation of neuropathies in the elderly.

Keywords: fiber size, immunologic, monoclonal gammopathy of undetermined significance (MGUS), neuropathy, quantitative sensory testing (QST)


Copyright © 1996-2000. The MIT Press . All rights reserved. ISSN 1526-8748